Vanilloid receptors
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Vanilloid_receptors".

content
transient receptor potential cation channel, subfamily V, member 1 [Homo sapiens]
Identifiers
Symbols TRPV1; DKFZp434K0220; VR1
External IDs OMIM: 602076 MGI: 1341787 HomoloGene: 12920
RNA expression pattern

More reference expression data
Orthologs
Human Mouse
Entrez 7442 193034
Ensembl ENSG00000196689 ENSMUSG00000005952
Uniprot Q8NER1 Q3V318
Refseq NM_018727 (mRNA)
NP_061197 (protein)		 NM_001001445 (mRNA)
NP_001001445 (protein)
Location Chr 17: 3.42 - 3.45 Mb Chr 11: 73.05 - 73.08 Mb
Pubmed search [1] [2]

The Transient receptor potential vanilloid 1 or TRPV1 can refer to the TRP cation channel receptor or the gene which encodes it in Homo sapiens.

TRPV1 is a nonselective ligand-gated cation channel that may be activated by a wide variety of exogenous and endogenous stimuli, including heat greater than 43°C, low pH, anandamide, N-arachidonoyl-dopamine, and capsaicin. TRPV1 receptors are found in the central nervous system and the peripheral nervous system and are involved in the transmission and modulation of pain, as well as the integration of diverse painful stimuli.[1][2]

Contents

Clinical significance

TRPV1 blockade in vivo elicited hyperthermia in multiple species, from rodents to humans, suggesting that TRPV1 is involved in body temperature maintenance.[3] Recently, AMG 517, a highly selective TRPV1 antagonist was dropped out of clinical trials due to the undesirable magnitude of hyperthermia.[4] A second molecule, SB-705498 was also evaluated in the clinic but its effect on body temperature was not reported.[5]

Peripheral nervous system

TRPV1 antagonists have shown efficacy in reducing nociception from inflammatory and neuropathic pain models in rats.[6] This provides evidence that TRPV1 is the capsaicin's sole receptor.[7]

In humans, drugs acting at TRPV1 receptors could potentially be used to treat neuropathic pain associated with multiple sclerosis, chemotherapy, or amputation, as well as pain associated with the inflammatory response of damaged tissue, such as in osteoarthritis.[8]

The role of TRPV1 in the regulation of body temperature has emerged in last few years. Based on a number of TRPV1 selective antagonists causing an increase in body temperature (hyperthermia), it was proposed that TRPV1 is tonically active in vivo and regulates body temperature.[3] In a recent report, it was found that tonically active TRPV1 channels are present in the viscera and keep an ongoing suppressive effect on body temperature.[9]

Central nervous system

TRPV1 is also expressed at high levels in the central nervous system and has been proposed as a target for treatment of not only pain but also for other conditions such as anxiety.[10] Furthermore TRPV1 appears to mediate long term depression (LTD) in the hippocampus.[11] LTD has been linked to a decrease in the ability to make new memories, unlike its opposite long term potentiation (LTP), which aids in memory formation. A dynamic pattern of LTD and LTP occuring at many synapses provides a code for memory formation. Long-term depression and subsequent prunning of dampened down synapses is important in memory formation. In rat brain slices, activation of TRV1 with heat or capsaicin induced LTD while capsazepine blocked capsaicin's ability to induce LTD.[11] Hence there may be therapeutic potential in antagonizing TRPV1 in the central nervous system, perhaps as a treatment for epilepsy (TRPV1 is already a target in the peripheral nervous system for pain relief).

See also

References

  1. ^ Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, Marsh K, Bianchi B, McDonald H, Niforatos W, Neelands TR, Moreland RB, Decker MW, Lee CH, Sullivan JP, Faltynek CR (2006). "TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists". J. Neurosci. 26 (37): 9385–93. doi:10.1523/JNEUROSCI.1246-06.2006. PMID 16971522. 
  2. ^ Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V (2002). "An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors". Proc. Natl. Acad. Sci. U.S.A. 99 (12): 8400–5. doi:10.1073/pnas.122196999. PMID 12060783. 
  3. ^ a b Gavva NR, Bannon AW, Surapaneni S, Hovland DN Jr, Lehto SG, Gore A, Juan T, Deng H, Han B, Klionsky L, Kuang R, Le A, Tamir R, Wang J, Youngblood B, Zhu D, Norman MH, Magal E, Treanor JJ, Louis JC (March 2007). "The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation". J. Neurosci. 27 (13): 3366–74. doi:10.1523/JNEUROSCI.4833-06.2007. PMID 17392452. 
  4. ^ Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, Jang GR, Kesslak JP, Ni L, Norman MH, Palluconi G, Rose MJ, Salfi M, Tan E, Romanovsky AA, Banfield C, Davar G (May 2008). "Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans". Pain 136 (1-2): 202–10. doi:10.1016/j.pain.2008.01.024. PMID 18337008. 
  5. ^ Chizh BA, O'Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, Bullman JN, Gray EJ, Lai RY, Williams PM, Appleby JM (November 2007). "The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans". Pain 132 (1-2): 132–41. doi:10.1016/j.pain.2007.06.006. PMID 17659837. 
  6. ^ Jhaveri MD, Elmes SJ, Kendall DA, Chapman V (2005). "Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats". Eur. J. Neurosci. 22 (2): 361–70. doi:10.1111/j.1460-9568.2005.04227.x. PMID 16045489. 
  7. ^ Story GM, Crus-Orengo L (2008). "Feel the Burn". American Scientist 95 (4): 326–333. ISSN 0003-0996. 
  8. ^ Gunthorpe MJ, Szallasi A (2008). "Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms". Curr. Pharm. Des. 14 (1): 32–41. PMID 18220816. 
  9. ^ Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, Bannon AW, Norman MH, Louis JC, Treanor JJ, Gavva NR, Romanovsky AA (July 2007). "Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors". J. Neurosci. 27 (28): 7459–68. doi:10.1523/JNEUROSCI.1483-07.2007. PMID 17626206. 
  10. ^ Starowicz K, Cristino L, Di Marzo V (2008). "TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications". Curr. Pharm. Des. 14 (1): 42–54. PMID 18220817. 
  11. ^ a b Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA (2008). "TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons". Neuron 57 (5): 746–59. doi:10.1016/j.neuron.2007.12.027. PMID 18341994. 

Further reading

  • Immke DC, Gavva NR (October 2006). "The TRPV1 receptor and nociception". Semin. Cell Dev. Biol. 17 (5): 582–91. doi:10.1016/j.semcdb.2006.09.004. PMID 17196854. 
  • Heiner I, Eisfeld J, Lückhoff A (2004). "Role and regulation of TRP channels in neutrophil granulocytes.". Cell Calcium 33 (5-6): 533–40. PMID 12765698. 
  • Geppetti P, Trevisani M (2004). "Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function.". Br. J. Pharmacol. 141 (8): 1313–20. doi:10.1038/sj.bjp.0705768. PMID 15051629. 
  • Clapham DE, Julius D, Montell C, Schultz G (2006). "International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.". Pharmacol. Rev. 57 (4): 427–50. doi:10.1124/pr.57.4.6. PMID 16382100. 
  • Szallasi A, Cruz F, Geppetti P (2007). "TRPV1: a therapeutic target for novel analgesic drugs?". Trends in molecular medicine 12 (11): 545–54. doi:10.1016/j.molmed.2006.09.001. PMID 16996800. 
  • Pingle SC, Matta JA, Ahern GP (2007). "Capsaicin receptor: TRPV1 a promiscuous TRP channel.". Handb Exp Pharmacol (179): 155–71. doi:10.1007/978-3-540-34891-7_9. PMID 17217056. 
  • Liddle RA (2007). "The role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitis.". Biochim. Biophys. Acta 1772 (8): 869–78. doi:10.1016/j.bbadis.2007.02.012. PMID 17428642. 

External links

v • d • e
Membrane transport protein: ion channels
Ca2+: Calcium channel
L-type/Cavα (1.1, 1.2, 1.3, 1.4) • N-type/Cavα2.2 • P-type/Cavα(2.1) • Q-type/Cavα2.1 • R-type/Cavα2.3 • T-type/Cavα(3.2)
α2δ-subunits (1, 2) • β-subunits (β1, β2, β3, β4) • γ-subunits (γ1, γ2, γ3, γ4)
Other
Na+: Sodium channel
Navα (1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 7A) • Navβ (1, 2, 3, 4)
Other
K+: Potassium channel
Kvα (1-6) (1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.10, 2.1, 2.2, 3.1, 3.2, 3.3, 3.4, 4.1, 4.2, 4.3, 5.1, 6.1, 6.2, 6.3, 6.4)
Kvα (7-12) (7.1, 7.2, 7.3, 7.4, 7.5, 8.1, 8.2, 9.1, 9.2, 9.3, 10.1, 10.2, 11.1/hERG, 11.2, 11.3, 12.1, 12.2, 12.3)
Kvβ (1, 2, 3) • KCNIP (1, 2, 3, 4) • minK/ISK • MiRP (1, 2, 3) • Shaker gene
Kir (1.1, 2.1, 2.2, 2.3, 2.4) • GIRK/Kir (3.1, 3.2, 3.3, 3.4) • Kir (4.1, 4.2, 5.1, 6.1, 6.2, 7.1)
K2P (1, 2, 3, 4, 5, 6, 7, 9, 10, 12, 13, 15, 16, 17, 18)
M+: TRP cation channel
TRPA (1) • TRPC (1, 2, 3, 4, 4AP, 5, 6, 7) • TRPM (1, 2, 3, 4, 5, 6, 7, 8) • TRPML (1, 2, 3) • TRPP (1, 2) • TRPV (1, 2, 3, 4, 5, 6)
Cl-: Chloride channel
CFTR • CLCA (1, 2, 3, 4) • CLCN (1, 2, 3, 4, 5, 6, 7, KA, KB) • CLIC (1, 2, 3, 4, 5, 6) • CLNS (1A, 1B)
Cyclic nucleotide-gated
α1, α2, α3, α4, β1, β3, H1, H2, H3, H4
Porin
Other/general


© jGames.co.uk 2007 (some content from Wikipedia under GDL ) !-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->
Your Ad Here